Literature DB >> 30200789

Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma.

Hamza Hashmi1, Mehdi Hamadani2, Farrukh T Awan3.   

Abstract

Entities:  

Keywords:  B-cell malignancies; Treatment options; non-Hodgkin lymphoma; relapsed disease

Year:  2018        PMID： 30200789     DOI： 10.1080/14656566.2018.1518430

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  1 in total

1.  Polatuzumab Vedotin for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Transplant-Ineligible Patients.

Authors:  Melanie Douglas
Journal:  J Adv Pract Oncol       Date:  2020-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.